FDA.reportPublic FDA data

aprepitant 32 MG per 4.4 ML Injection

RxCUI
2631783
RxNorm name
aprepitant 32 MG per 4.4 ML Injection
Display name
aprepitant 32 MG per 4.4 ML Injection
Full name
aprepitant 32 MG per 4.4 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:22

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
APONVIEAPREPITANTHeron Therapeutics, Inc.d1b111eb-659a-496b-a86a-8f0fa370f1472026-04-01Warnings, Adverse reactionsExact identifier
rxcui: 2631783

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
d1b111eb-659a-496b-a86a-8f0fa370f147aprepitant 32 MG in 4.4 ML Injection [PSN] · 4.4 ML aprepitant 7.2 MG/ML Injection [SCD] · aprepitant 32 MG per 4.4 ML Injection [SY]38These highlights do not include all the information needed to use APONVIE ® safely and effectively. See full prescribing information for APONVIE. APONVIE ® (aprepitant) injectable emulsion, for intravenous use Initial U.S. Approval: 200320260401